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Abstract
Transcription factor regulation of gene expression and
chromatin-controlled epigenetic memory systems are
closely cooperating in establishing the pluripotent state
of embryonic stem (ES) cells and maintaining cell fate
decisions throughout development of an organism. A
thorough understanding of the regulatory transcriptional
circuitry that rules the underlying plastic yet heritable
gene expression programs in ES cells is of great impor-
tance. With the advent of next-generation sequencing
technologies facilitating the quantitative assessment of
functional genomics assays it is now feasible to interro-
gate transcription networks at a genome-wide scale.
Here, we discuss the application of next-generation
sequencing in elucidating the molecular mechanisms
underlying ES cell function.
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Introduction: memory of gene expression
programs in the development of an organism
We all originate from a single cell, the fertilized egg.
During the process of development – cell number
increases – cells start to become different and specialize.
This is a hierarchical process with progressive restriction
of developmental potentials of cells in a lineage from
intermediate stages down to the fully committed specific
cell type (Reik, 2007). Although all different cell types
(with few exceptions) in a mammalian organism contain
the same genetic content, the fate of a cell is defined by
its specific settings of gene expression. Once a cell is
directed towards a particular developmental route the
gene expression program characterizing its identity has
to be memorized over the following cell divisions until the
terminal differentiation state is reached. The impact of
such a memory system becomes obvious when cells
escape their fate to enter the detrimental track of tumor
formation, a process in which the cancer cells have for-
gotten their original destiny.
As there are no genetic changes involved in cell fate
determination events, the heritability of transcription
states has to occur at an epigenetic level. The term epi-
genetics describes the inheritance of gene expression
patterns independent of the underlying DNA sequence.
In vertebrates, epigenetic gene regulation is based on the
methylation of DNA at cytosines as well as on the mod-
ulation of chromatin structure (Bernstein et al., 2007).
DNA methylation is the best-known epigenetic modi-
fication. It plays a major role in basic processes, such as
X chromosome inactivation, chromosomal stability and
parental imprinting. CpG sites, as targets for the methyl-
ation, are not randomly distributed in the genome;
instead, there are CpG-rich regions known as CpG
islands located in the promoter regions of a large fraction
of genes (Gardiner-Garden and Frommer, 1987). CpG
islands are usually not modified in the early stage of
development but can become methylated during cellular
differentiation leading to a repression of the targeted
genes (Meissner et al., 2008; Mohn et al., 2008). The
propagation of DNA methylation has been well-char-
acterized as a replication-coupled process involving a
maintenance DNA methyltransferase that copies the
methylation mark present at the parent strand to the
daughter strand, thereby assuring the epigenetic inheri-
tance of the signal from one cell generation to the follow-
ing one (Goll and Bestor, 2005).
The central building block of chromatin is the nucleo-
some consisting of a defined stretch of DNA wrapped
around an octamer of four different histone proteins. The
packaging of DNA into nucleosomes constitutes a con-
straint to processes where protein factors need to have
access to DNA (Struhl, 1999). However, chromatin is not
a simple barrier for DNA dependent processes but
is a regulatory platform that ensures the tight control of
gene expression states. Biochemical mechanisms have
evolved that employ chromatin functionality to regulate
nuclear processes, such as gene expression. Protein
composites known as chromatin remodeling complex-
es can physically rearrange nucleosomes on DNA to
generate closed (repressed) or open (active) chromatin
structures influencing the accessibility for DNA binding
proteins (Cairns, 2005). Additionally, there is a multi-
faceted interplay between enzymes that can modify
particular amino acid residues in the tail regions of nucle-
osomal histone proteins and those that remove the
modifications (Kouzarides, 2007). These histone modi-
fications are implicated in controlling gene expression
and genome function by establishing dedicated chro-
matin environments and orchestrating DNA dependent
processes. Especially methylation of lysine residues
has been considered, similar to cytosine methylation, a
potential mark for carrying epigenetic information that is
stably maintained through cell divisions. A current model
for the propagation of histone marks suggests a self-
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Figure 1 Outline of ChIP-seq.
Cells (most ideally a homogeneous cell type, cell cycle stage, etc.) are fixed by formaldehyde resulting in covalent DNA-protein
crosslinks (1). The fixed cells are sonicated to isolate and shear chromatin to the size of 150–1000 bp fragments. To enrich and purify
the chromatin fragments bound by the protein of interest, a specific antibody is added for immunoprecipitation (2). The crosslinks
are reversed and the DNA purified (3). A DNA library is generated by end repair, adaptor ligation, and limited PCR amplification (4).
Subsequently, the DNA fragments undergo a clonal amplification step specific to the sequencing platform used (5). After parallel
sequencing millions of fragments enriched in the ChIP sample the sequence reads are mapped to the reference genome (6). Two
enriched genomic regions are shown and the directionality of sequenced reads is indicated by dark and light blue and red. In (7)
calculated ChIP-seq profiles of two proteins are depicted (green) together with the RNA profile generated by RNA-seq of the poly(A)-
mRNA fraction (blue).
perpetuation after the deposition of new nucleosomes
behind the replication fork by means of positive-
feedback loops (Hansen et al., 2008).
To understand the gene regulatory networks that gov-
ern cell fate determination and maintenance, it is crucial
to reveal the mutual functional dependency of sequence
specific transcription factors, the RNA polymerase
machinery and the epigenetic regulatory system. Experi-
mentally this requires addressing the questions of where
the transcription factors and chromatin regulators are
located within the genome and how changes in the pro-
tein binding or histone modification patterns correlate
with changes in the transcriptional program and cell
state.
Principles of parallel sequencing and its
application to quantify functional states
The key methodology to detect direct physical interac-
tions between proteins and DNA in vivo is chromatin
immunoprecipitation (ChIP). In ChIP experiments, an
antibody specific for a DNA binding factor or histone
modification is used to enrich for target DNA sites to
which the protein was bound in a living cell (Figure 1).
The enriched DNA sites are then identified and quanti-
fied. For the large genomes of mammals, it has been
difficult to achieve ChIP measurements that combine
high accuracy, the comprehensiveness of an entire
genome, and high binding-site resolution.
Recently, the development of new high-throughput
sequencing technologies – generally referred to as
‘deep’, ‘high-throughput’, ‘(massive) parallel’ or ‘next-
generation’ sequencing technologies – enable a new way
of quantifying genome-scale functional assays, such as
ChIP or transcription profiling (Holt and Jones, 2008).
Three different approaches represented by the technol-
ogies from Roche, Illumina, and ABI have recently been
extensively applied for these purposes. In general, a DNA
library with immunoprecipitated fragments, combined
with specific adaptor sequences at both sides, becomes
sequenced from one end or from both ends in a highly
paralleled shotgun fashion without a detour via bacterial
cloning steps (Figure 1). In particular, the Illumina
Genome Analyzer and the ABI Solid system have proven
to be well suited for the analysis requirements of func-
tional genomics applications. They generate millions of
short sequence reads of ;30 nucleotides per sequenc-
ing run which can be mapped to the reference genome.
Owing to the huge amount of reads, it is possible to reli-
ably calculate the frequency of fragments in a complex
mixture of DNA molecules (Wold and Myers, 2008).
Desired levels of sensitivity and statistical certainty
required to detect rare molecules can be achieved by
adjusting the total number of reads. In this way, ChIP-
enriched DNA can be quantitatively analyzed to identify
overrepresented fragments in the mixture that might
correspond to genomic locations where the protein of
interest was bound. The analysis of ChIP assays by next-
generation sequencing, called ChIP-seq, offers a higher
resolution than microarray based analyses (ChIP-chip).
Additionally, ChIP-seq offers an affordable genome-
wide output for mammalian genomes with minimal
hands-on processing using less input material and
a rapid analysis pipeline that relies on ‘simple’ count-
ing sequenced reads (Mardis, 2007). Next-generation
sequencing analysis can be applied to the quantification
of any DNA or any other nucleic acid sample that can be
converted to DNA. Besides ChIP-seq, currently the most
prominent approaches comprise profiling of mRNA
populations (RNA-seq) and the identification of small
RNA samples, such as miRNAs, which play a crucial role
in post-transcriptional regulation (Morin et al., 2008; Mor-
tazavi et al., 2008). In both cases, the sequencing adap-
tors are incorporated during the process of cDNA library
generation. In the case of transcription profiling, RNA-
seq shows a broader dynamic signal range of expression
levels with up to five orders of magnitude and seems to
be much more sensitive than traditional microarray
applications (Mortazavi et al., 2008). Recent studies on
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Table 1 Sequencing depth and mapping summary of
ChIPped proteins from mouse ES cells.
Protein  total  mapped Sites
mapped reads* reads* bound
Marson et al., 2008
Oct4 8.76 3.37 17 255
Sox2 25.44 5.67 15 085
Nanog 17.80 6.03 16 688
Suz12 7.69 2.51 3434
Tcf3 11.54 6.11 6291
H3K4me3 10.92 6.94 19 632
H3K79me2 7.6 4.18 28 694
H3K36me3 9.4 4.53 15 463
Chen et al., 2008
Oct4 9.31 5.69 3761
Sox2 9.27 5.78 4526
Nanog 12.76 8.82 10 343
Suz12 8.77 6.12 4215
STAT3 9.89 6.23 2546
Smad1 5.32 3.39 1126
Tcfcp2l1 12.62 9.47 26 910
CTCF 5.82 3.80 39 609
Zfx 6.67 4.62 10 338
Klf4 7.40 4.34 10 875
Esrrb 10.70 7.94 21 647
c-Myc 10.69 7.20 3422
n-Myc 10.19 5.52 7182
E2f1 12.46 8.97 20 699
p300 8.83 5.69 524
Proteins indicated in bold font have been analyzed in
both studies. The differences in the numbers of bind-
ing sites result most probably because of the use of
different antibodies and different criteria to define
thresholds. All ChIPs have been analyzed with an Illu-
mina GA1 with a read length of 26 bases. *Numbers
are reported as millions of reads.
different mammalian cell systems reported 25–75%more
identified transcripts (Cloonan et al., 2008; Sultan et al.,
2008; Tang et al., 2009). By aligning the reads to refer-
ence transcripts or their de novo assembly, new splice
variants can be annotated and thus one gains exact
information on its structure in addition to the expression
level of a transcript. Small RNA species can now be iden-
tified by simple gel purification of RNA samples migrating
at the nucleotide length of interest, usually 20–30 nt, and
sequencing the sample. All functional assays analyzed by
next-generation sequencing have in common that an a
priori knowledge of the genomic regions of interest is not
required as the reads can be mapped to the entire ref-
erence genome. This will ultimately lead to a complete
annotation of coding and non-coding transcription units
of the human genome as well as of the genomes of the
many organisms of interest.
Technical details of the different next-generation
sequencing platforms and the details on the different
methods, including ChIP-seq, RNA-seq, and others,
have been reviewed elsewhere (Mardis, 2007; Holt and
Jones, 2008; Wang et al., 2009). In this review, we will
focus on the application of next-generation sequencing
in the dissection of regulatory circuits controlling embry-
onic stem (ES) cell function which has been the focus of
much attention in recent publications.
Next-generation ES cell research
Many studies over the recent years have acclaimed
the exceptional role of ES cells for basic and applied
research. ES cells are derived from the inner cell mass of
the mammalian blastocyst. They are pluripotent and can
give rise to all cell types of the adult organism. At the
same time they have the potential to self-renew and can
be kept for extended periods of time in culture, making
them an important model for developmental biology and
a promising resource for regenerative medicine (Jaenisch
and Young, 2008). The molecular mechanisms underlying
the establishment and maintenance of pluripotency in
ES cells are of great interest. The knowledge of the tran-
scription factors and epigenetic modifications operating
in a regulatory network will facilitate both directed
programming of ES cells to specific lineages and the
reprogramming of somatic cells to an ES-like state. The
pluripotent state of ES cells is established by the action
of key transcription factors, such as Oct4, Sox2, and
Nanog. Cell fate decisions are accompanied by epige-
netic modifications, which ensure the stable inheri-
tance of the underlying gene expression patterns. In this
regard, it is important to determine how transcription fac-
tor networks interact with different epigenetic regulatory
systems to achieve this stability.
Until recently, attention has been focused almost
exclusively on the role of the transcription factors Oct4,
Sox2, and Nanog (Orkin, 2005). In a study published in
2008 Chen and colleagues demonstrated the power of
next-generation sequencing technology by lifting the
analysis of the transcription factor network of mouse ES
cells to the next level of complexity (Chen et al., 2008).
They produced ChIP-seq maps of 13 transcription fac-
tors well known for their functional roles in mouse ES
cells and found 1100–40 000 binding sites with specific-
ity greater than 95% determined by parallel ChIP-qPCR
analysis (Table 1). Most interestingly, the study showed
two distinct regulatory networks with one defined by
the clustered binding of Oct4, Nanog, Sox2, Smad1,
and STAT3. Smad1 and STAT3 are the effector molecules
of two signaling pathways crucial for self-renewal. This
clearly illustrates the convergence of these signaling
pathways with the core ES cell transcriptional circuitry
defined by Oct4, Nanog, and Sox2 at common target
genes. The striking feature of ChIP-seq to interrogate the
entire genome without being limited to promoter regions
also showed benefits as the majority of Oct4-Nanog-
Sox2 binding sites were found outside promoter regions.
Intriguingly, the authors could demonstrate with 25 out
of 25 regions tested, that these sequences show ES cell
specific enhancer activity. Other transcription factors
analyzed in this study comprised c-Myc, Klf4, Zfx, and
Esrrb which have been previously shown to be important
for self-renewal of ES cells and for reprogramming of
somatic cells to induced pluripotent stem cells. In this
way, Chen and colleagues provided an unprecedented
dataset enabled by the use of massive parallel sequenc-
ing technology, which paves the way for the understand-
ing of the transcription regulatory network in ES cells and
for the identification of additional factors required for self-
renewal, pluripotency, and reprogramming functions.
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ChIP-seq’ing chromatin signals of ES cells
To understand the role of histone modifications in gene
expression and cell fate decisions or – conversely – to
enable the prediction of gene expression states and to
determine the fate of a cell by looking at histone modi-
fication patterns, Mikkelsen et al. started to generate
comprehensive maps of certain histone modifications
across the whole genome of three mouse pluripotent
and lineage-committed cell lines by means of ChIP-seq
(Mikkelsen et al., 2007). They concentrated on histone
modifications for which the function had been well defin-
ed previously. Trimethylation of histone H3 at lysine 27
(H3K27me3) is a mark for repressive chromatin set by
Polycomb group proteins (PcG). PcG proteins play a fun-
damental and evolutionary highly conserved role in the
epigenetic regulation of gene expression during devel-
opment by heritably maintaining the repressed state of
major developmental genes (Ringrose and Paro, 2004).
Conversely H3K4me3 is generally associated with active
chromatin. Previous ChIP-chip studies showed a colo-
calization of these histone modifications in ES cells,
which was confirmed by Mikkelsen et al. using ChIP-seq
(Mikkelsen et al., 2007; Sharov and Ko, 2007). These
regions have been referred to as bivalent domains. How-
ever, in the meantime several studies demonstrated that
bivalent domains are not specific for ES cells but rather
a function of the CpG content of the underlying promoter
(Mohn and Schu¨beler, 2009). All CpG-rich promoters
are targeted by H3K4 methylation in ES cells whereby
repressed developmental genes are concomitantly meth-
ylated at H3K27. Mikkelsen et al. and others have dem-
onstrated that differentiation to a multipotent progenitor
state can lead to dynamic changes at bivalent domains
with the loss of H3K4me3 or H3K27me3 at then
repressed or active promoters. As such, the tracking of
these histone modifications at key regulatory genes
might help to distinguish developmental potential and
state of a certain cell. In this regard, the same group of
researchers followed H3K4me3 and H3K27me3 by ChIP-
seq analysis in the process of induced reprogramming of
somatic cells (Mikkelsen et al., 2008). Such a genome-
wide analysis for different cell states would have been
virtually impossible before the advent of next-generation
sequencing. Interestingly, ChIP-seq analysis could
also be used to identify allele specific transcription
(Mikkelsen et al., 2007). The co-occurrence of H3K9me3
with H3K4me3 delineates imprinting control regions in ES
cells. This knowledge they applied to screen the genome
of ES cells derived from a cross of two distantly related
mouse strains providing 3.5 million single nucleotide
polymorphisms (SNPs) for imprinting control regions by
means of H3K9me3 and H3K4me3 ChIP-seq analysis.
Then, they utilized ChIP-seq of H3K36me3 to look at
active transcription units and searched for allelic imbal-
ance of SNP distribution. Using this approach, the
authors could identify novel regions showing allele-
specific gene expression, suggesting that ChIP-seq is a
powerful tool for this purpose – under the prerequisite of
having sufficient sequencing coverage and dense maps
of SNPs.
H3K36me3 had already previously been linked to tran-
scriptional elongation. Remarkably, Mikkelsen et al. could
show that H3K36me3 in combination with H3K4me3
seems to be ideally suited to annotate unknown 39- or
59-regions of genes or entire new transcription units
(Mikkelsen et al., 2007). A peak of H3K4me3 indicates
the transcription start site and H3K36me3 marks the
entire transcribed gene body. This finding promoted a
study to use ‘K4–K36 domains’ identified by ChIP-seq
analysis to screen the mouse genome for the presence
of large intervening non-coding RNAs (lincRNAs) residing
outside of protein coding genes (Guttman et al., 2009).
This was an interesting approach as many studies over
recent years concentrated on the identification and func-
tional dissection of such non-coding RNAs, demon-
strating that these transcripts play important roles in
imprinting and gene regulation. Guttman and coworkers
identified more than 1200 K4–K36 domains with at least
5 kb in size. Further functional and bioinformatics exam-
inations revealed that the majority of these domains pro-
duce multiexonic, non-protein coding RNAs expressed in
different cell types. Comparison with ChIP-seq data for
the pluripotency factors Oct4 and Nanog indicated that
these proteins bind to 118 lincRNA promoters, which
also show an expression profile characteristic for genes
involved in maintaining the pluripotent state of ES cells.
They also noted that one of these lincRNAs had been
uncovered in an RNAi screening approach (by serendipity
as the study aimed for protein-coding transcripts) to
identify genes involved in mouse ES cell proliferation and
was found as one of the top hits. This promises that we
can expect many new regulatory pathways to be
revealed in ES cells involving non-coding RNAs which
have been discovered by means of functional genomics
approaches using the new massive parallel sequencing
technologies.
A similar approach to identify another class of non-
coding RNAs has been undertaken by Marson et al.
(2008). They concentrated on micro-RNAs (miRNAs) as
potential major players in the regulatory circuitry under-
lying ES cell self-renewal and pluripotency. Several
hundred of mature miRNAs have been identified in the
human genome previously. Information on their transcrip-
tional regulatory regions, however, is lacking in most
cases because they are expressed as polycistronic RNAs
(primary miRNAs), which become rapidly processed. To
assess their role in the core transcriptional circuitry of ES
cells, it is essential to identify their promoter regions and
thereby binding sites for potential transcription factors
regulating miRNA expression. Utilizing genome-wide
histone modification landmarks, such as H3K4me3 and
H3K36me3, from several other studies Marson and
colleagues identified promoters of 185 primary miRNAs
in mouse and of 294 in human corresponding to 336
and 441 mature miRNAs, respectively. To find connec-
tions between miRNA expression regulation and the core
factors specifying ES cell functions, the authors used
ChIP-seq to identify the binding sites of Oct4, Sox2,
Nanog, and Tcf3 in mouse ES cells (Tcf3 has been shown
to repress pluripotency genes in ES cells under certain
culture conditions). Here, it will also be interesting to cor-
relate this dataset with the ChIP-seq data generated by
ChIP-seq analysis of embryonic stem cells 1143
Article in press - uncorrected proof
Chen et al. (2008) to gain a more comprehensive over-
view of the transcription factor network (Table 1). Further
functional approaches comprising miRNA expression
profiling by quantitative massive parallel sequencing in
ES cells and more differentiated cell states indicated that
miRNAs bound by the investigated transcription factor
quartet are regulated by these factors in pluripotent cells.
Furthermore, this study revealed that Oct4-Sox2-Nanog-
Tcf3 bound miRNA gene loci silenced in ES cells are also
bound by the PcG protein SUZ12 and are marked by
H3K27me3. Upon differentiation into certain lineages
they lose H3K27me3 and become expressed, whereas in
other tissues they stay silenced. This demonstrates that
the PcG system is involved in regulating and maintaining
the expression state of tissue specific miRNAs. In sum-
mary, Marson et al. impressively enabled the integration
of different layers of molecular regulatory mechanisms –
DNA sequence specific transcription factors, chromatin
modifiers, and miRNAs – governing ES cell identity at the
transcriptional and post-transcriptional level.
Conclusions and future directions
Without doubt, genome-scale chromatin profiling en-
hanced by the advent of next-generation sequencers has
revolutionized current research in the field of functional
genomics. The mere throughput of ChIP samples that
can be analyzed facilitates a new way of approaching a
comprehensive dissection of entire gene regulatory net-
works underlying cell fate decisions. Technical improve-
ments of the current sequencing technologies and new
developments in this field will increase read number out-
put per sequencing run, which will (1) improve data qual-
ity by gaining a higher sequence coverage and (2) boost
sample throughput as multiplexing (sequencing of differ-
ently ‘barcoded’ samples in one sequencing run) will
become an option.
To fully understand transcriptional networks it is essen-
tial to correlate the protein binding and histone modifi-
cation profiles with gene expression data. Based on cost
and throughput, current gene expression profiling relies,
in majority, on traditional microarray techniques but sev-
eral studies using quantitative massive parallel sequenc-
ing for the analysis of isolated mRNA have started to
challenge the predominance of microarray approaches.
The advantages of RNA-seq are becoming obvious:
Cloonan et al. (2008) described 59% more transcripts in
mouse ES cells and embryoid bodies (a differentiation
step after the ES cell state) compared with microarrays.
Even more remarkable, Tang et al. demonstrated the fea-
sibility of single cell RNA-seq with an isolated mouse
blastomere and reported 75% more genes than microar-
rays (Tang et al., 2009). In addition, the identification of
unknown splicing events is possible – Tang and col-
leagues revealed more than 1700 new splice junctions –
as well as the discovery of transcription units outside of
annotated exons – Cloonan et al. found more than 30%
of identifiable reads in non-annotated regions. These
approaches illustrate that a comprehensive understand-
ing of gene regulation events has to lead via quantitative
sequencing measurements of the transcriptome, which
provide many advantages over traditional microarray
analysis (reviewed by Wang et al., 2009).
All studies described depict the linear distribution of
chromatin bound factors along the genome, which is
an intrinsic outcome of classical ChIP assays. Genomic
DNA, however, is organized in a three-dimensional
manner that – most probably – also influences the gene
expression program and cellular fate. Methods have
been developed to reveal intra- and interchromosomal
interactions, such as the 3C or the 6C technologies
(Dekker et al., 2002; Tiwari et al., 2008). 3C generates a
library of DNA fragments that reflects literally all interac-
tions and could be utilized in combination with massive
parallel sequencing for the analysis of the three-dimen-
sional chromatin structure genome-wide. Furthermore,
the 6C method combines ChIP with 3C. Thereby, a DNA
library becomes generated (susceptible for parallel
sequencing analysis) which is enriched for fragments
reflecting chromatin loops between binding sites of the
ChIP purified protein.
Probably the biggest challenge for the future will be to
integrate all functional genomics datasets to develop a
comprehensive picture of the transcriptional networks
comprising DNA sequence specific transcription factors,
epigenetic regulators, and histone modifications, as well
as regulatory long non-coding RNAs and post-transcrip-
tionally acting miRNAs. The beginning of this endeavor
seems very promising proven by the studies described
in this review but many more have to follow. It is unques-
tionably attractive to pursue the goal towards the full
understanding of the gene regulatory network underlying
cell fate decisions and their maintenance. It will facilitate
the quantitative and predictive description of these pro-
cesses, which will ultimately lead to a comprehensive
understanding of human development, as well as to an
efficient application of ES cells in regenerative medicine.
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